EPAS1 and osteosarcoma: HIF2PUT inhibited in vitro osteosarcoma CSC proliferation and migration, the sphere-forming ability of MG-63 cells and decreased the CD133-positive cells [62], while others observed that HIF2PUT overexpression inhibited CSC migration and invasion through HIF2α downregulation [204].